Literature DB >> 12700131

Focal adhesion kinase in cancer.

Timothy P Hecker1, Candece L Gladson.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor cytoplasmic tyrosine kinase that transmits signals important in modulating several cell functions, including proliferation, migration, and survival. Several different types of malignant tumors have been reported to express elevated levels of FAK protein in vivo, potentially pointing to a role for FAK in either the progression of tumor cells to malignancy or the pathogenesis of cancer. Considerable knowledge has been gained regarding FAK signaling in non-neoplastic cells, such as fibroblasts, while much less is known regarding FAK signaling in malignant cells. Several studies to date suggest that the regulation of FAK activity and signaling may be different in malignant cells. In this review, we summarize what is known regarding the function and signaling of FAK in cancer cells, and highlight areas that need further study. Evidence is emerging that aberrant FAK expression, activity, and signaling can potentially promote the progression of several types of tumors in vivo through its effects on cell function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700131     DOI: 10.2741/1115

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.

Authors:  Reshu Gupta; Arun Kumar Nalla; Venkateswara Rao Gogineni; Chandramu Chetty; Praveen Bhoopathi; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

4.  In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.

Authors:  Markus J Riemenschneider; Wolf Mueller; Rebecca A Betensky; Gayatry Mohapatra; David N Louis
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  Regulation of Focal Adhesion Kinase through a Direct Interaction with an Endogenous Inhibitor.

Authors:  Taylor J Zak; Yevgenia E Koshman; Allen M Samarel; Seth L Robia
Journal:  Biochemistry       Date:  2017-08-23       Impact factor: 3.162

Review 6.  Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.

Authors:  Tanya A Rege; Constance Y Fears; Candece L Gladson
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

7.  Paxillin phosphorylation and complexing with Erk and FAK are regulated by PLD activity in MDA-MB-231 cells.

Authors:  Jelena Pribic; Derrick Brazill
Journal:  Cell Signal       Date:  2012-03-28       Impact factor: 4.315

8.  The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary.

Authors:  Claudia D Andl
Journal:  J Oncol       Date:  2010-09-30       Impact factor: 4.375

9.  Expression of FAK and PTEN in bronchioloalveolar carcinoma and lung adenocarcinoma.

Authors:  Changli Wang; Ran Yang; Dongsheng Yue; Zhenfa Zhang
Journal:  Lung       Date:  2009-02-26       Impact factor: 2.584

10.  Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells.

Authors:  Lili Liu; Xiaoxuan Ning; Li Sun; Yongquan Shi; Shuang Han; Changcun Guo; Yu Chen; Shiren Sun; Fang Yin; Kaichun Wu; Daiming Fan
Journal:  Mol Cell Biochem       Date:  2007-05-03       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.